No Data
No Data
GOSSAMER BIO Earnings Preview: Recent $GOSS Insider Trading, Hedge Fund Activity, and More
H.C. Wainwright Maintains Gossamer Bio(GOSS.US) With Buy Rating, Maintains Target Price $10
Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.
Buy Rating for Gossamer Bio: Seralutinib's Transformative Potential in Pulmonary Hypertension
After Losing 0.7% in the Past Year, Gossamer Bio, Inc. (NASDAQ:GOSS) Institutional Owners Must Be Relieved by the Recent Gain
Gossamer Bio Reports 2024 Financial Results and Progress
loading...